Literature DB >> 32632818

GTPase Activity of MxB Contributes to Its Nuclear Location, Interaction with Nucleoporins and Anti-HIV-1 Activity.

Linlin Xie1, Zhao Ju1, Chaojie Zhong1, Yingjun Wu1, Yuxing Zan1, Wei Hou2, Yong Feng3.   

Abstract

The human myxovirus resistance 2 (Mx2/MxB) protein, a member of interferon (IFN)-inducible dynamin-like large GTPases, restricts a number of virus infections. Inhibition of these viruses occurs at poorly-defined steps after viral entry and has a common requirement for MxB oligomerization. However, the GTPase activity is essential for the anti-viral effects of MxB against herpesviruses and HBV but not HIV-1. To understand the role of MxB GTPase activity, including GTP binding and GTP hydrolysis, in restriction of HIV-1 infection, we genetically separated these two functions and evaluated their contributions to restriction. We found that both the GTP binding and hydrolysis function of MxB involved in the restriction of HIV-1 replication. The GTPase activity of MxB contributed to its nuclear location, interaction with nucleoporins (NUPs) and HIV-1 capsids. Furthermore, MxB disrupted the association between NUPs and HIV-1 cores dependently upon its GTPase activity. The function of GTPase activity was therefore multi-faceted, led to fundamentally distinct mechanisms employed by wild-type MxB and GTPase activity defective MxB mutations to restrict HIV-1 replication.

Entities:  

Keywords:  Anti-viral activity; Capsid (CA); GTPase activity; Human immunodeficiency virus type 1 (HIV-1); Human myxovirus resistance 2 (MxB); Nucleoporin

Year:  2020        PMID: 32632818      PMCID: PMC7973321          DOI: 10.1007/s12250-020-00249-8

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  32 in total

1.  A quantitative assay for HIV DNA integration in vivo.

Authors:  S L Butler; M S Hansen; F D Bushman
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

Review 2.  Mx proteins: antiviral gatekeepers that restrain the uninvited.

Authors:  Judith Verhelst; Paco Hulpiau; Xavier Saelens
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

3.  Contribution of MxB oligomerization to HIV-1 capsid binding and restriction.

Authors:  Cindy Buffone; Bianca Schulte; Silvana Opp; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

4.  Role of nucleotide binding and GTPase domain dimerization in dynamin-like myxovirus resistance protein A for GTPase activation and antiviral activity.

Authors:  Alexej Dick; Laura Graf; Daniel Olal; Alexander von der Malsburg; Song Gao; Georg Kochs; Oliver Daumke
Journal:  J Biol Chem       Date:  2015-03-31       Impact factor: 5.157

5.  The interferon-inducible MxB protein inhibits HIV-1 infection.

Authors:  Zhenlong Liu; Qinghua Pan; Shilei Ding; Jin Qian; Fengwen Xu; Jinming Zhou; Shan Cen; Fei Guo; Chen Liang
Journal:  Cell Host Microbe       Date:  2013-09-19       Impact factor: 21.023

6.  Equine MX2 is a restriction factor of equine infectious anemia virus (EIAV).

Authors:  Kristina Meier; Ananda Ayyappan Jaguva Vasudevan; Zeli Zhang; Ariane Bähr; Georg Kochs; Dieter Häussinger; Carsten Münk
Journal:  Virology       Date:  2018-08-03       Impact factor: 3.616

7.  Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.

Authors:  Yong-Xiang Wang; Matthias Niklasch; Tiantian Liu; Yang Wang; Bisheng Shi; Wenjie Yuan; Thomas F Baumert; Zhenghong Yuan; Shuping Tong; Michael Nassal; Yu-Mei Wen
Journal:  J Hepatol       Date:  2019-12-18       Impact factor: 25.083

8.  Host and viral determinants of Mx2 antiretroviral activity.

Authors:  Idoia Busnadiego; Melissa Kane; Suzannah J Rihn; Hannah F Preugschas; Joseph Hughes; Daniel Blanco-Melo; Victoria P Strouvelle; Trinity M Zang; Brian J Willett; Chris Boutell; Paul D Bieniasz; Sam J Wilson
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

9.  A triple-arginine motif in the amino-terminal domain and oligomerization are required for HIV-1 inhibition by human MX2.

Authors:  Caroline Goujon; Rebecca A Greenbury; Stelios Papaioannou; Tomas Doyle; Michael H Malim
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

10.  CryoEM structure of MxB reveals a novel oligomerization interface critical for HIV restriction.

Authors:  Frances J D Alvarez; Shaoda He; Juan R Perilla; Sooin Jang; Klaus Schulten; Alan N Engelman; Sjors H W Scheres; Peijun Zhang
Journal:  Sci Adv       Date:  2017-09-15       Impact factor: 14.136

View more
  3 in total

1.  Exposing the invader.

Authors:  Avraham N Bayer; Fred L Homa
Journal:  Elife       Date:  2022-05-30       Impact factor: 8.713

2.  The interferon-inducible GTPase MxB promotes capsid disassembly and genome release of herpesviruses.

Authors:  Manutea C Serrero; Virginie Girault; Sebastian Weigang; Todd M Greco; Ana Ramos-Nascimento; Fenja Anderson; Antonio Piras; Ana Hickford Martinez; Jonny Hertzog; Anne Binz; Anja Pohlmann; Ute Prank; Jan Rehwinkel; Rudolf Bauerfeind; Ileana M Cristea; Andreas Pichlmair; Georg Kochs; Beate Sodeik
Journal:  Elife       Date:  2022-04-27       Impact factor: 8.713

3.  High accumulation of Mx2 renders limited multiplication of oncolytic herpes simplex virus-1 in human tumor cells.

Authors:  Yong Ren; Meiling Chen; Guangxian Wu; Dongmei Ji; Grace Guoying Zhou; Pei-Gen Ren; Wenmin Fu
Journal:  Sci Rep       Date:  2021-10-27       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.